Azenta, Inc. (AZTA)

Latest Insider Confidence Score

2026Q1

49.8
Bearish

Company insider confidence (by quarter)

2013Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Koffey Quentin — 4,611,752 Nov 4, 2024
Politan Capital Management LP — 4,611,752 Nov 4, 2024
Politan Capital Management GP LLC — 4,611,752 Nov 4, 2024
Politan Capital Partners GP LLC — 4,611,752 Nov 4, 2024
Schwartz Stephen S CEO 446,536 Nov 17, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 6, 2026 Cornog William L Director Neutral 52.5 - 0.00% ✗ -
Feb 6, 2026 Feb 6, 2026 Nova Tina Susan Director Neutral 90.0 +5,663 56.02% ✗ -
Feb 5, 2026 Feb 6, 2026 Cornog William L Director Neutral 52.5 - 0.00% ✗ -
Feb 5, 2026 Feb 6, 2026 Madaus Martin D Director Neutral 52.5 - 0.00% ✗ -
Feb 5, 2026 Feb 6, 2026 Doshi Dipal Director Neutral 90.0 +5,663 140.17% ✗ -
Feb 5, 2026 Feb 6, 2026 Casal Frank Director Neutral 90.0 +7,243 49.75% ✗ -
Feb 5, 2026 Feb 6, 2026 McLaughlin Erica Director Neutral 90.0 +5,663 33.59% ✗ -
Feb 5, 2026 Feb 6, 2026 Davis Robyn C Director Neutral 52.5 - 0.00% ✗ -
Nov 24, 2025 Dec 3, 2025 Marotta John CEO Neutral 90.0 +118,194 124.42% ✗ -
Nov 24, 2025 Nov 25, 2025 Marotta John CEO Neutral 90.0 +122,269 128.70% ✗ -
Nov 24, 2025 Nov 25, 2025 Lin Lawrence Y. CFO Neutral 90.0 +36,681 85.36% ✗ -
Nov 24, 2025 Nov 25, 2025 Pirogova Olga SVP and CHRO Neutral 90.0 +16,303 97.42% ✗ -
Nov 24, 2025 Nov 25, 2025 Zhou Ginger SVP and GM, Multiomics Neutral 90.0 +13,042 50.72% ✗ -
Nov 24, 2025 Nov 25, 2025 Starr Ephraim SVP, Gen Counsel & Secretary Neutral 90.0 +34,235 90.62% ✗ -
May 16, 2025 Nov 25, 2025 Cornog William L Director Buy 95.0 +7,000 37.24% ✗ $189.9K
Nov 25, 2025 Cornog William L Director Neutral 52.5 - 0.00% ✗ -
Nov 25, 2025 Madaus Martin D Director Neutral 52.5 - 0.00% ✗ -
Nov 14, 2025 Nov 17, 2025 Zhou Ginger SVP and GM, Multiomics Sell 46.3 -1,118 -4.17% ✗ $33.3K
Nov 14, 2025 Nov 17, 2025 Pirogova Olga SVP and CHRO Sell 46.3 -1,553 -8.49% ✗ $46.2K
Nov 14, 2025 Nov 17, 2025 Lin Lawrence Y. CFO Sell 42.5 -3,039 -6.60% ✗ $90.4K
Nov 14, 2025 Nov 17, 2025 Marotta John CEO Sell 40.0 -10,980 -10.36% ✗ $326.7K
Aug 12, 2025 Nov 14, 2025 Pirogova Olga SVP and CHRO Sell 26.3 -1,085 -5.60% ✗ $31K
Jun 2, 2025 Nov 14, 2025 Marotta John CEO Buy 68.8 +1,000 0.94% ✗ $26K
May 30, 2025 Nov 14, 2025 Malus Alan J Director Buy 97.5 +12,000 238.33% ✗ $319.8K
Nov 14, 2025 Lin Lawrence Y. CFO Neutral 52.5 - 0.00% ✗ -
Aug 12, 2025 Nov 14, 2025 Zhou Ginger SVP and GM, Multiomics Sell 26.3 -1,085 -3.89% ✗ $31K
Sep 10, 2025 Sep 12, 2025 Marotta John CEO Sell 52.5 -316 -0.30% ✗ $9.3K
Aug 12, 2025 Aug 13, 2025 Zhou Ginger SVP and GM, Multiomics Sell 46.3 -1,085 -3.89% ✗ $31K
Aug 12, 2025 Aug 13, 2025 Pirogova Olga SVP and CHRO Sell 46.3 -1,085 -5.60% ✗ $31K
Aug 11, 2025 Aug 12, 2025 Lin Lawrence Y. CFO Buy 90.0 +2,500 5.75% ✗ $69.9K
Jun 2, 2025 Jun 4, 2025 Marotta John CEO Neutral 67.5 +1,000 0.94% ✗ -
May 8, 2025 Jun 4, 2025 Marotta John CEO Neutral 85.0 +5,433 5.39% ✗ -
May 30, 2025 Jun 3, 2025 Malus Alan J Director Neutral 90.0 +12,000 238.33% ✗ -
May 15, 2025 May 27, 2025 Starr Ephraim SVP, Gen Counsel & Secretary Neutral 90.0 +37,779 100.00% ✗ -
May 27, 2025 Starr Ephraim SVP, Gen Counsel & Secretary Neutral 52.5 - 0.00% ✗ -
May 16, 2025 May 20, 2025 Cornog William L Director Neutral 90.0 +7,000 47.44% ✗ -
May 8, 2025 May 12, 2025 Lin Lawrence Y. CFO Neutral 90.0 +6,000 15.99% ✗ -
May 8, 2025 May 12, 2025 Marotta John CEO Neutral 82.5 +5,433 2.67% ✗ -
Feb 11, 2025 Feb 13, 2025 Lin Lawrence Y. CFO Neutral 85.0 +2,200 6.23% ✗ -
Feb 7, 2025 Feb 11, 2025 Koffey Quentin Director Neutral 55.0 +4,040 0.09% ✗ -
Feb 7, 2025 Feb 11, 2025 Malus Alan J Director Neutral 90.0 +4,040 406.03% ✗ -
Feb 7, 2025 Feb 11, 2025 Casal Frank Director Neutral 90.0 +5,168 55.03% ✗ -
Feb 7, 2025 Feb 11, 2025 Davis Robyn C Director Neutral 90.0 +4,040 13.65% ✗ -
Feb 7, 2025 Feb 11, 2025 Nova Tina Susan Director Neutral 90.0 +4,040 66.57% ✗ -
Feb 7, 2025 Feb 11, 2025 Doshi Dipal Director Neutral 90.0 +4,040 100.00% ✗ -
Feb 7, 2025 Feb 11, 2025 Madaus Martin D Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 11, 2025 Cornog William L Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 11, 2025 McLaughlin Erica Director Neutral 90.0 +4,040 31.52% ✗ -
Feb 3, 2025 Feb 4, 2025 Hughes Violetta VP, Chief Accounting Officer Sell 46.3 -317 -3.20% ✗ $16.8K
Feb 4, 2025 Doshi Dipal Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Feb 4, 2025 Zhou Ginger SVP and General Manager, Genom Buy 78.8 +417 1.52% ✗ $19.1K
Dec 5, 2024 Dec 9, 2024 Lin Lawrence Y. CFO Neutral 90.0 +28,813 443.28% ✗ -
Dec 4, 2024 Dec 5, 2024 Wang David Dong SVP & GM, SMS Sell 50.0 -140 -0.58% ✗ $6.5K
Dec 2, 2024 Lin Lawrence Y. CFO Neutral 52.5 - 0.00% ✗ -
Nov 19, 2024 Nov 21, 2024 Pirogova Olga SVP and CHRO Sell 46.3 -548 -2.75% ✗ $22K
Nov 19, 2024 Nov 21, 2024 Hughes Violetta VP, Chief Accounting Officer Sell 47.5 -163 -1.62% ✗ $6.5K
Nov 19, 2024 Nov 21, 2024 Zhou Ginger SVP and General Manager, Genom Sell 46.3 -491 -1.75% ✗ $19.7K
Nov 19, 2024 Nov 21, 2024 Wang David Dong SVP & GM, SMS Sell 46.3 -348 -1.42% ✗ $13.9K
Nov 19, 2024 Nov 21, 2024 Joseph Jason SVP, General Counsel, Secy. Sell 46.3 -1,139 -1.00% ✗ $45.6K
Nov 19, 2024 Nov 21, 2024 Cueto Herman CFO Sell 46.3 -712 -2.89% ✗ $28.5K
Nov 15, 2024 Nov 19, 2024 Marotta John CEO Buy 97.5 +97,588 2981.64% ✗ $552.9K
Nov 15, 2024 Nov 19, 2024 Pirogova Olga SVP and CHRO Neutral 90.0 +10,381 108.82% ✗ -
Nov 15, 2024 Nov 19, 2024 Joseph Jason SVP, General Counsel, Secy. Neutral 90.0 +13,841 13.86% ✗ -
Nov 18, 2024 Nov 19, 2024 Cornog William L Director Buy 97.5 +12,500 554.32% ✗ $495K
Nov 18, 2024 Nov 19, 2024 HIRSCH DIDIER Director Buy 91.3 +1,000 40.57% ✗ $39.5K
Nov 15, 2024 Nov 19, 2024 Hughes Violetta VP, Chief Accounting Officer Neutral 90.0 +6,921 218.88% ✗ -
Nov 15, 2024 Nov 19, 2024 Wang David Dong SVP & GM, SMS Neutral 90.0 +8,651 54.72% ✗ -
Nov 15, 2024 Nov 19, 2024 Zhou Ginger SVP and General Manager, Genom Neutral 90.0 +8,651 44.73% ✗ -
Nov 19, 2024 Nov 19, 2024 Madaus Martin D Director Buy 95.0 +4,940 200.41% ✗ $201.4K
Nov 6, 2024 Nov 14, 2024 Malus Alan J Director Buy 91.3 +995 100.00% ✗ $46.3K
Nov 14, 2024 Malus Alan J Director Neutral 52.5 - 0.00% ✗ -
Nov 6, 2024 Nov 8, 2024 Cornog William L Director Sell 26.3 -995 -30.62% ✗ $46.3K
Nov 8, 2024 Cornog William L Director Neutral 52.5 - 0.00% ✗ -
Nov 6, 2024 Nov 8, 2024 Koffey Quentin Director Neutral 47.5 +995 0.02% ✗ -
Nov 4, 2024 Politan Capital Management LP Other Neutral 52.5 - 0.00% ✗ -
Oct 17, 2024 Oct 21, 2024 Cueto Herman CFO Sell 42.5 -1,595 -6.09% ✗ $69.7K
Sep 11, 2024 Marotta John CEO Neutral 52.5 - 0.00% ✗ -
Sep 9, 2024 Sep 11, 2024 Marotta John CEO Neutral 90.0 +3,273 100.00% ✗ -
Aug 9, 2024 Aug 13, 2024 Cueto Herman CFO Neutral 90.0 +11,309 75.95% ✗ -
Aug 9, 2024 Aug 13, 2024 Wang David Dong SVP & GM, SMS Neutral 90.0 +6,333 66.82% ✗ -
Aug 9, 2024 Aug 13, 2024 Pirogova Olga SVP and CHRO Neutral 90.0 +6,333 197.47% ✗ -
Aug 9, 2024 Aug 13, 2024 Joseph Jason SVP, General Counsel, Secy. Neutral 90.0 +10,856 12.20% ✗ -
Aug 9, 2024 Aug 13, 2024 Zhou Ginger SVP and General Manager, Genom Neutral 90.0 +6,333 48.69% ✗ -
Jan 31, 2024 Aug 2, 2024 Zhou Ginger SVP and General Manager, Genom Neutral 60.0 +64 0.49% ✗ -
Jan 31, 2024 Aug 2, 2024 Vacha Robin SVP, GM Life Science Products Neutral 60.0 +151 0.48% ✗ -
Aug 1, 2024 Aug 1, 2024 Joseph Jason SVP, General Counsel, Secy. Sell 45.0 -1,000 -1.11% ✓ $62.1K
Jul 25, 2024 Jul 29, 2024 Joseph Jason SVP, General Counsel, Secy. Sell 37.5 -3,000 -3.23% ✓ $180K
May 20, 2024 May 22, 2024 Hughes Violetta VP, Chief Accounting Officer Sell 26.3 -584 -15.59% ✗ $30K
Apr 1, 2024 Apr 2, 2024 Joseph Jason SVP, General Counsel, Secy. Sell 45.0 -1,000 -1.06% ✓ $60.2K
Mar 7, 2024 Mar 11, 2024 Joseph Jason SVP, General Counsel, Secy. Sell 22.5 -13,000 -12.15% ✓ $856K
Feb 12, 2024 Feb 13, 2024 Davis Robyn C Director Neutral 85.0 +2,465 9.09% ✗ -
Feb 12, 2024 Feb 13, 2024 Rosenblatt Michael Director Neutral 90.0 +2,465 23.31% ✗ -
Feb 12, 2024 Feb 13, 2024 Madaus Martin D Director Neutral 90.0 +2,465 100.00% ✗ -
Feb 12, 2024 Feb 13, 2024 McLaughlin Erica Director Neutral 90.0 +2,465 23.81% ✗ -
Feb 12, 2024 Feb 13, 2024 Bousa Edward Peter Director Neutral 27.5 -2,465 -50.00% ✗ -
Feb 12, 2024 Feb 13, 2024 HIRSCH DIDIER Director Neutral 90.0 +2,465 100.00% ✗ -
Feb 12, 2024 Feb 13, 2024 Nova Tina Susan Director Neutral 27.5 -2,465 -28.88% ✗ -
Feb 12, 2024 Feb 13, 2024 Casal Frank Director Neutral 90.0 +3,603 62.24% ✗ -
Feb 1, 2024 Feb 2, 2024 Zhou Ginger SVP and General Manager, Genom Neutral 82.5 +448 3.59% ✗ -
Feb 2, 2024 HIRSCH DIDIER Director Neutral 52.5 - 0.00% ✗ -